+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Modality (Computed Tomography Scan, Magnetic Resonance Imaging), By Therapeutic Area, By Services, By End Use, Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 200 Pages
  • November 2024
  • Region: Global
  • Grand View Research
  • ID: 5415433
The global clinical trial imaging market size is expected to reach USD 1.91 billion by 2030, registering a CAGR of 7.8% from 2025 to 2030. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.

The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities such as EMA and FDA to discuss study design or defend study results.

Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuro-imaging. Imaging biomarkers are effective in radiological reads. This provides the reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility

Clinical Trial Imaging Market Report Highlights

  • The reading and analytical services segment held the largest market share at 30.95% in 2024 and is expected to grow at a CAGR of 8.4% from 2025 to 2030, highlighting its critical role in ensuring the accuracy and reliability of imaging data in clinical research.
  • The biotechnology and pharmaceutical companies segment accounted for the largest share of 28.7% in 2024. The factor attributing to the dominance of this segment is the need to develop new drugs and therapies to cure chronic diseases.
  • Oncology segment held the largest market share of 23.63% in 2024. High prevalence of cancer cases and the constant need for new and innovative therapies to treat various types of cancer are expected to fuel the market growth.
  • The contract research organizations (CROs) segment is expected to grow significantly with a CAGR of 8.5% over the forecast period, owing to its essential role in developing new drugs and therapies for chronic diseases.
  • North America dominated the market with a revenue share of 47.93% in 2024 due to the increasing geriatric population, along with chronic diseases and growing demand for treatment options.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Modality
1.2.2. Therapeutic Area
1.2.3. Services
1.2.4. End Use
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. Therapeutic area outlook
2.2.3. Services outlook
2.2.4. End Use outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Clinical Trial Imaging Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing number of pharmaceutical and biotechnological companies
3.2.1.2. Growing number of contract research organization (CRO)
3.2.1.3. Increasing research and development investments
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of machineries and installations
3.3. Clinical Trial Imaging Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Clinical Trial Imaging Market: Modality Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Clinical Trial Imaging Market: Modality Movement Analysis
4.3. Clinical Trial Imaging Market by Modality Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Computed Tomography Scan
4.5.1. Computed Tomography Scan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Magnetic Resonance Imaging
4.6.1. Magnetic Resonance Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. X-Ray
4.7.1. X-Ray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Ultrasound
4.8.1. Ultrasound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Optical Coherence Tomography (OCT)
4.9.1. Optical Coherence Tomography (OCT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.10. Other Modalities
4.10.1. Other Modalities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Clinical Trial Imaging Market: Therapeutic Area Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Clinical Trial Imaging Market: Therapeutic Area Movement Analysis
5.3. Clinical Trial Imaging Market by Therapeutic Area Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Neurovascular Diseases
5.5.1. Neurovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Cardiovascular Diseases
5.6.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Orthopedics & MSK Disorders
5.7.1. Orthopedics & MSK Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Oncology
5.8.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Ophthalmology
5.9.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Nephrology
5.10.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.11. Other Therapeutic Areas
5.11.1. Other Therapeutic Areas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Clinical Trial Imaging Market: Services Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Clinical Trial Imaging Market: Services Movement Analysis
6.3. Clinical Trial Imaging Market by Services Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Clinical Trial Design and Consultation Services
6.5.1. Clinical Trial Design and Consultation Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Reading and Analytical Services
6.6.1. Reading and Analytical Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Operational Imaging Services
6.7.1. Operational Imaging Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. System and Technology Support Services
6.8.1. System and Technology Support Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Project and Data Management
6.9.1. Project and Data Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Clinical Trial Imaging Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Clinical Trial Imaging Market: End Use Movement Analysis
7.3. Clinical Trial Imaging Market by End Use Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Biotechnology and Pharmaceutical Companies
7.5.1. Biotechnology and Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Medical Devices Manufacturers
7.6.1. Medical Devices Manufacturers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Academic and Government Research Institutes
7.7.1. Academic and Government Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Contract Research Organizations (CROs)
7.8.1. Contract Research Organizations (CROs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. Other End Users
7.9.1. Other End Users Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Clinical Trial Imaging Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. U.S.
8.5.1.1. Key country dynamics
8.5.8.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. Canada
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Europe
8.6.1. UK
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.8.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Germany
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. France
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework/ reimbursement structure
8.6.3.3. Competitive scenario
8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. Italy
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework/ reimbursement structure
8.6.4.3. Competitive scenario
8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Spain
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework/ reimbursement structure
8.6.5.3. Competitive scenario
8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Norway
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework/ reimbursement structure
8.6.6.3. Competitive scenario
8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Sweden
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework/ reimbursement structure
8.6.7.3. Competitive scenario
8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.6.8. Denmark
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory framework/ reimbursement structure
8.6.8.3. Competitive scenario
8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
8.7.8. Japan
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. China
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. India
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Australia
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.5. South Korea
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework/ reimbursement structure
8.7.5.3. Competitive scenario
8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.7.6. Thailand
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory framework/ reimbursement structure
8.7.6.3. Competitive scenario
8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework/ reimbursement structure
8.8.1.3. Competitive scenario
8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. Argentina
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework/ reimbursement structure
8.8.2.3. Competitive scenario
8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. Middle East & Africa
8.9.1. South Africa
8.9.1.1. Key country dynamics
8.9.1.2. Regulatory framework/ reimbursement structure
8.9.1.3. Competitive scenario
8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.9.2. Saudi Arabia
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory framework/ reimbursement structure
8.9.2.3. Competitive scenario
8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.9.3. UAE
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory framework/ reimbursement structure
8.9.3.3. Competitive scenario
8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.9.4. Kuwait
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory framework/ reimbursement structure
8.9.4.3. Competitive scenario
8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.1.1 Company/Competition Categorization
9.1.2. Innovators
9.2. Vendor Landscape
9.2.1. List of key distributors and channel partners
9.2.2. Key customers
9.2.3. Key company market share analysis, 2024
9.2.4. IXICO plc
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Navitas Life Sciences
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Resonance Health
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. ProScan Imaging
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Radiant Sage LLC
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Medpace
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Biomedical Systems Corp.
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives
9.2.11. Cardiovascular Imaging Technologies
9.2.11.1. Company overview
9.2.11.2. Financial performance
9.2.11.3. Product benchmarking
9.2.11.4. Strategic initiatives
9.2.12. Intrinsic Imaging
9.2.12.1. Company overview
9.2.12.2. Financial performance
9.2.12.3. Product benchmarking
9.2.12.4. Strategic initiatives
9.2.13. BioTelemetry
9.2.13.1. Company overview
9.2.13.2. Financial performance
9.2.13.3. Product benchmarking
9.2.13.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America clinical trial imaging market, by region, 2018 - 2030 (USD Million)
Table 3 North America clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 4 North America clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 5 North America clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 6 North America clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 7 U.S. clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 8 U.S. clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 9 U.S. clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 10 U.S. clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 11 Canada clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 12 Canada clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 13 Canada clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 14 Canada clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 15 Mexico clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 16 Mexico clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 17 Mexico clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 18 Mexico clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe clinical trial imaging market, by region, 2018 - 2030 (USD Million)
Table 20 Europe clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 21 Europe clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 22 Europe clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 23 Europe clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 24 Germany clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 25 Germany clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 26 Germany clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 27 Germany clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 28 UK clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 29 UK clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 30 UK clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 31 UK clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 32 France clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 33 France clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 34 France clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 35 France clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 36 Italy clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 37 Italy clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 38 Italy clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 39 Italy clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 40 Spain clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 41 Spain clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 42 Spain clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 43 Spain clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 44 Sweden clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 45 Sweden clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 46 Sweden clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 47 Sweden clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 48 Denmark clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 49 Denmark clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 50 Denmark clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 51 Denmark clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 52 Norway clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 53 Norway clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 54 Norway clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 55 Norway clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 56 Asia Pacific clinical trial imaging market, by region, 2018 - 2030 (USD Million)
Table 57 Asia Pacific clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 58 Asia Pacific clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 59 Asia Pacific clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 60 Asia Pacific clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 61 China clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 62 China clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 63 China clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 64 China clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 65 Japan clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 66 Japan clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 67 Japan clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 68 Japan clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 69 India clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 70 India clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 71 India clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 72 India clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 73 Australia clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 74 Australia clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 75 Australia clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 76 Australia clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 77 South Korea clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 78 South Korea clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 79 South Korea clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 80 South Korea clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 81 Thailand clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 82 Thailand clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 83 Thailand clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 84 Thailand clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 85 Latin America clinical trial imaging market, by region, 2018 - 2030 (USD Million)
Table 86 Latin America clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 87 Latin America clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 88 Latin America clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 89 Latin America clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 90 Brazil clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 91 Brazil clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 92 Brazil clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 93 Brazil clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 94 Argentina clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 95 Argentina clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 96 Argentina clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 97 Argentina clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 98 Middle East and Africa clinical trial imaging market, by region, 2018 - 2030 (USD Million)
Table 99 Middle East and Africa clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 100 Middle East and Africa clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 101 Middle East and Africa clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 102 Middle East and Africa clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 103 South Africa clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 104 South Africa clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 105 South Africa clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 106 South Africa clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 111 UAE clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 112 UAE clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 113 UAE clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 114 UAE clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
Table 115 Kuwait clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 116 Kuwait clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
Table 117 Kuwait clinical trial imaging market, by services, 2018 - 2030 (USD Million)
Table 118 Kuwait clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 clinical trial imaging market: market outlook
Fig. 14 clinical trial imaging market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Clinical trial imaging market driver impact
Fig. 20 Clinical trial imaging market restraint impact
Fig. 21 Clinical trial imaging market strategic initiatives analysis
Fig. 22 Clinical trial imaging market: Modality movement analysis
Fig. 23 Clinical trial imaging market: Modality outlook and key takeaways
Fig. 24 Computed tomography scan market estimates and forecast, 2018 - 2030
Fig. 25 Magnetic resonance imaging market estimates and forecast, 2018 - 2030
Fig. 26 X-Ray market estimates and forecast, 2018 - 2030
Fig. 27 Ultrasound market estimates and forecast, 2018 - 2030
Fig. 28 Optical coherence tomography (OCT) market estimates and forecast, 2018 - 2030
Fig. 29 Other modalities market estimates and forecast, 2018 - 2030
Fig. 30 Clinical trial imaging market: Therapeutic area movement analysis
Fig. 31 Clinical trial imaging market: Therapeutic area outlook and key takeaways
Fig. 32 Neurovascular diseases market estimates and forecast, 2018 - 2030
Fig. 33 Cardiovascular diseases market estimates and forecast, 2018 - 2030
Fig. 34 Oncology market estimates and forecast, 2018 - 2030
Fig. 35 Ophthalmology market estimates and forecast, 2018 - 2030
Fig. 36 Nephrology market estimates and forecast, 2018 - 2030
Fig. 37 Other therapeutic areas market estimates and forecast, 2018 - 2030
Fig. 38 Clinical trial imaging market: Services movement analysis
Fig. 39 Clinical trial imaging market: Services outlook and key takeaways
Fig. 40 Clinical trial design and consultation services market estimates and forecast, 2018 - 2030
Fig. 41 Reading and analytical services market estimates and forecast, 2018 - 2030
Fig. 42 Operational imaging services market estimates and forecast, 2018 - 2030
Fig. 43 System and technology support services market estimates and forecast, 2018 - 2030
Fig. 44 Project and data management market estimates and forecast, 2018 - 2030
Fig. 45 Clinical trial imaging market: End use movement analysis
Fig. 46 Clinical trial imaging market: End use outlook and key takeaways
Fig. 47 Biotechnology companies market estimates and forecast, 2018 - 2030
Fig. 48 Medical devices manufacturers market estimates and forecast, 2018 - 2030
Fig. 49 Academic and government research institutes market estimates and forecast, 2018 - 2030
Fig. 50 Contract research organizations (CROs) market estimates and forecast, 2018 - 2030
Fig. 51 Other end users market estimates and forecast, 2018 - 2030
Fig. 52 Global clinical trial imaging market: Regional movement analysis
Fig. 53 Global clinical trial imaging market: Regional outlook and key takeaways
Fig. 54 Global market shares and leading players
Fig. 55 North America market share and leading players
Fig. 56 Europe market share and leading players
Fig. 57 Asia Pacific market share and leading players
Fig. 58 Latin America market share and leading players
Fig. 59 Middle East & Africa market share and leading players
Fig. 60 North America
Fig. 61 North America market estimates and forecast, 2018 - 2030
Fig. 62 U.S.
Fig. 63 U.S. market estimates and forecast, 2018 - 2030
Fig. 64 Canada
Fig. 65 Canada market estimates and forecast, 2018 - 2030
Fig. 66 Mexico
Fig. 67 Mexico market estimates and forecast, 2018 - 2030
Fig. 68 Europe
Fig. 69 Europe. market estimates and forecast, 2018 - 2030
Fig. 70 UK
Fig. 71 UK market estimates and forecast, 2018 - 2030
Fig. 72 Germany
Fig. 73 Germany market estimates and forecast, 2018 - 2030
Fig. 74 France
Fig. 75 France market estimates and forecast, 2018 - 2030
Fig. 76 Italy
Fig. 77 Italy market estimates and forecast, 2018 - 2030
Fig. 78 Spain
Fig. 79 Spain market estimates and forecast, 2018 - 2030
Fig. 80 Sweden
Fig. 81 Sweden market estimates and forecast, 2018 - 2030
Fig. 82 Denmark
Fig. 83 Denmark market estimates and forecast, 2018 - 2030
Fig. 84 Norway
Fig. 85 Norway market estimates and forecast, 2018 - 2030
Fig. 86 Asia Pacific
Fig. 87 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 88 China
Fig. 89 China market estimates and forecast, 2018 - 2030
Fig. 90 Japan
Fig. 91 Japan market estimates and forecast, 2018 - 2030
Fig. 92 India
Fig. 93 India market estimates and forecast, 2018 - 2030
Fig. 94 Australia
Fig. 95 Australia market estimates and forecast, 2018 - 2030
Fig. 96 South Korea
Fig. 97 South Korea market estimates and forecast, 2018 - 2030
Fig. 98 Thailand
Fig. 99 Thailand market estimates and forecast, 2018 - 2030
Fig. 100 Latin America
Fig. 101 Latin America market estimates and forecast, 2018 - 2030
Fig. 102 Brazil
Fig. 103 Brazil market estimates and forecast, 2018 - 2030
Fig. 104 Argentina
Fig. 105 Argentina market estimates and forecast, 2018 - 2030
Fig. 106 Middle East and Africa
Fig. 107 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 108 Saudi Arabia
Fig. 109 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 110 South Africa
Fig. 111 South Africa market estimates and forecast, 2018 - 2030
Fig. 112 UAE
Fig. 113 UAE market estimates and forecast, 2018 - 2030
Fig. 114 Kuwait
Fig. 115 Kuwait market estimates and forecast, 2018 - 2030
Fig. 116 Participant categorization- Clinical trial imaging market
Fig. 117 Market share of key market players- Clinical trial imaging market

Companies Mentioned

  • IXICO plc
  • Navitas Life Sciences
  • Resonance Health
  • ProScan Imaging
  • Radiant Sage LLC
  • Medpace
  • Biomedical Systems Corp
  • Cardiovascular Imaging Technologies
  • Intrinsic Imaging
  • BioTelemetry

Methodology

Loading
LOADING...

Table Information